Stocks make the largest movements premarket: Pfizer, Pepsico, Palantir, Merck and more
View the companies that get the heads before the bell: Pfizer-de Pharmaceutic Shares have added 1.8% on better than expected ...
Friday, March 28, 2025
ADVERTISEMENT
Tag: Merck
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Exterior view of the entrance to Merck headquarters on February 5, 2024 in Rahway, New Jersey.Spencer Platt | Getty ImagesMerck ...
Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall
The exterior view of the entrance to Merck's headquarters in Rahway, New Jersey, on February 5, 2024.Spencer Platt | Getty ...
US health advisers back Pfizer and Merck pneumonia vaccines for adults over 50
A key panel of US health advisers voted in favor of lowering the age recommendation for Pfizer Inc and Merck ...
Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
Merck's logo will be displayed on a screen at the New York Stock Exchange on November 17, 2021.Andrew Kelly | ...
Stocks Making the Biggest Premarket Moves: Boeing, Dell, Merck and More
Check out the companies making the biggest moves in premarket trading: Boeing — Shares rose 4% after the planemaker reached ...
Merck shares fall 9% despite earnings beat, strong demand for top drugs like Keytruda
The exterior view of the entrance to Merck's corporate headquarters in Rahway, New Jersey, on February 5, 2024.Spencer Platt | ...
Stocks Making the Biggest Moves in Premarket: CrowdStrike, Merck, PayPal, JetBlue and More
See the companies making headlines in premarket trading. CrowdStrike — Shares fell 5% after CNBC reported that Delta Airlines has ...
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections
Zoom in iconArrows pointing outwardsMerck's new pneumococcal vaccine. Courtesy: MerckThe Food and Drug Administration approved it on Monday Merck's new ...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
Modern And Merck on Monday released more positive three-year data on their experimental vaccine, given to patients with the most ...
